SureTrader Nadex Advertisement
Home > Boards > US Listed > Biotechs >

Anthera Pharmaceuticals, Inc. (ANTH)

ANTH RSS Feed
Add ANTH Price Alert      Hide Sticky   Hide Intro
Moderator:
Search This Board: 
Last Post: 2/24/2017 5:18:55 PM - Followers: 62 - Board type: Free - Posts Today: 0


 


 Anthera Pharmaceuticals Inc.     


                                              Nasdaq: ANTH


 

Anthera Pharmaceuticals is a biopharmaceutical company focused on advancing the development and commercialization of innovative medicines that benefit patients with unmet medical needs. The company has two product candidates in development.

 

Sollpura is Anthera’s novel biotechnology-derived pancreatic enzyme replacement therapy for the potential treatment of exocrine pancreatic insufficiency in patients with cystic fibrosis.

Blisibimod is Anthera’s BAFF inhibitor for the potential treatment of systemic lupus erythematosus and IgA nephropathy.


Pipeline



                            Contact Info                                                                           
                                                                           

Anthera Pharmaceuticals, Inc. 

25801 Industrial Blvd, Suite B • Hayward, CA 94545



Press Contact: [email protected]


Business Development: [email protected]


 Vendors: [email protected]


 Website: www.anthera.com

 

------>>Latest Developments<<-----

December 06, 2016

J. Craig Thompson promoted to Chief Executive Officer and appointed to the Board of Directors Paul F. Truex appointed as Executive Chairman of the Board Dr. Christopher Henney stepped down as Chairman ...

1
 
         
___________________________________________________________________________________________________________________________________________
Outstanding Share Data
October 31 ,2016,the Company had 41,955,126 common shares issued and outstanding
July 31,2016 the Company had 41,427,352 common shares issued and outstanding
April 27,2016 the Company had 40,987,145 common shares issued and outstanding
February 29,2016 the Company had 40,004,037 common shares issued and outstanding
November 1,2015 the Company had 39,875,405 common shares issued and outstanding
August 1,2015 the Company had 39,703,998 common shares issued and outstanding
May 1,2015 the Company had 35,816,364 common shares issued and outstanding
February 28,2015 the Company had 29,091,773 common shares issued and outstanding
November 10,2014 the Company had 22,939,553 common shares issued and outstanding
____________________________________________________________________________________________________________________________________________

MAJOR HOLDERS

 

68% of the outstanding owned by these longs

Outstanding 42mil minus Major ownership of 28.5mil = 13.5mil free trading float


28.5mil Major Holders in this,15mil Institutions,7.5mil Direct Holders,6mil Mutual Funds= 68% of 42mil os 


http://www.barrons.com/quote/stock/us/xnas/anth?mod=DNH_S

________________________________________________________________


http://finance.yahoo.com/q?s=ANTH

   Anthera Pharmaceuticals is a biopharmaceutical company focused on developing and commercializing products to treat serious diseases associated with inflammation,

including cardiovascular and autoimmune diseases. We currently have a Phase 2 clinical program, blisibimod.It was just recently approved by FDA to move into

PHASE 3

 

   Blisibimod targets elevated levels of B-cell activating factor (BAFF), which has been associated with a variety of B-cell mediated autoimmune diseases, including systemic lupus erythematosus (SLE), rheumatoid arthritis, multiple sclerosis, Sjögren's Syndrome, Graves' Disease and others.


  It has taken the lupus research community over 50 years to produce a new therapy. Although it is now a year old, Benlysta (belimumab),

now marketed by GlaxoSmithKline and Human Genome Sciences, is the first human monoclonal antibody for the treatment

of lupus.




  Benlysta had a slow take-off grossing $59.2 million in sales in the last three quarters of 2011, but it was approved in numerous

countries by year's end.
Estimated sales for Benlysta in 2012 are said to be about $230 million, with first annual profits likely by 2015.


  The surprisingly slow uptake of Benlysta allows for blisibimod to develop into a promising drug as

it currently has more desirable features than that of Benlysta.


Blisibimod has a dosing regimen of one injection weekly, compared to that of Benlysta which requires a

series of dosing before the maintenance dose begins. Also, Benlysta has limitations on usage pertaining to

specific patient populations and has not been studied in combination with other biologics.

These attributes of blisibimod including a different mechanism of action, will set it apart from

Benlysta, Global Data concludes.

 

 

  • 1D
  • 1M
  • 2M
  • 3M
  • 6M
  • 1Y
  • 2Y
  • 3Y
  • 5Y
ANTH
Current Price
Volume:
Bid Ask Day's Range
SureTrader
ANTH News: Current Report Filing (8-k) 05:02 PM
ANTH News: Anthera Pharmaceuticals Provides Business Update and Reports 2016 Fourth Quarter and Fiscal Year Financial Results 04:05 PM
ANTH News: Proxy Statement - Notice of Shareholders Meeting (preliminary) (pre 14a) 02/24/2017 04:58:31 PM
ANTH News: Current Report Filing (8-k) 02/16/2017 04:46:57 PM
ANTH News: Amended Statement of Ownership (sc 13g/a) 02/14/2017 12:58:42 PM
News News Alert: Current Report Filing (8-k) 02/27/2017 05:02:33 PM
PostSubject
#2016   ANTH doing a reverse split Atlanta1 02/24/17 05:18:55 PM
#2015   * * $ANTH Video Chart 02-22-17 * * ClayTrader 02/22/17 05:24:16 PM
#2014   http://investorshub.advfn.com/boards/read_msg.aspx?message_id=128916729 [SMART MONEY] 02/22/17 03:43:54 PM
#2013   Next leg coming? BluSkies 02/17/17 01:29:19 PM
#2012   * * $ANTH Video Chart 02-15-17 * * ClayTrader 02/15/17 05:25:28 PM
#2011   Nice chart IMO BluSkies 02/13/17 11:00:48 AM
#2010   On watch BluSkies 02/10/17 03:30:18 PM
#2009   Holding long BluSkies 02/06/17 11:20:38 AM
#2008   Great place to sell..... idiots Tbone88 02/06/17 10:01:43 AM
#2007   Lmfao. Down 5 cents on 138k shares. Tbone88 02/06/17 09:49:46 AM
#2006   Jumped in Friday at 7:30 PM and slapped Steel_city 02/05/17 02:50:01 PM
#2005   Who thinks that they pump this one back Jclassy 02/04/17 01:13:06 PM
#2004   Back to $1 soon? BluSkies 02/03/17 02:31:01 PM
#2003   Something is brewing wantabetrader 02/03/17 10:10:16 AM
#2002   Something leaked Tbone88 02/03/17 10:04:34 AM
#2001   Chart same picture like yesterday before spike into. l2 hunter 01/27/17 11:56:15 AM
#2000   .60 Break today? shurtha2000 01/27/17 11:36:07 AM
#1999   This is a potential double opportunity for me... BluSkies 01/27/17 11:19:41 AM
#1998   Agree ANTH looks great. Also load a starter l2 hunter 01/27/17 09:41:18 AM
#1997   ANTH up up away Latinachica 01/26/17 05:35:28 PM
#1996   * * $ANTH Video Chart 01-26-17 * * ClayTrader 01/26/17 05:27:09 PM
#1995   back up to 1$ or more kurt_vdh 01/26/17 03:57:20 PM
#1994   Nice bounce thus far BluSkies 01/26/17 02:54:13 PM
#1993   ANTH .57 bouncing PAC 01/26/17 02:37:26 PM
#1992   HIT my oversold parameters today..i am loading this am Blutribe 01/26/17 09:39:01 AM
#1991   Bounce! BluSkies 01/26/17 09:37:53 AM
#1990   Could go right back over $2 waiting on shurtha2000 01/26/17 02:13:50 AM
#1989   On watch for a bounce BluSkies 01/24/17 03:15:20 PM
#1988   next stop .35 shurtha2000 01/24/17 09:56:54 AM
#1987   wrong board - sorry kei 01/23/17 10:19:49 PM
#1986   out at .72 + on 1/3, back in Atlanta1 01/05/17 10:43:00 AM
#1985   Higher low's being set here. Looking good. GoHighOrGoHigh 01/04/17 12:26:09 PM
#1984   Bottom bounce? BluSkies 01/03/17 03:23:12 PM
#1983   Really bullish if it could turn this inside PAC 01/03/17 03:10:56 PM
#1982   trying to make a move here.. Atlanta1 01/03/17 03:03:15 PM
#1981   Nice. Been seeing it being accumulated. It'll bounce PAC 01/03/17 02:11:07 PM
#1980   in sub .68 this morning.. Atlanta1 01/03/17 02:10:10 PM
#1979   ANTH .68 inside day so far. let's try PAC 01/03/17 02:09:06 PM
#1978   * * $ANTH Video Chart 12-28-16 * * ClayTrader 12/28/16 04:58:25 PM
#1977   lol grow up, pal.. Atlanta1 12/28/16 04:18:33 PM
#1976   $ANTH ROFLMFAO $ANTH = pure retail garbage myopinion 12/28/16 04:15:22 PM
#1975   doubled up sub .70 Atlanta1 12/28/16 03:01:16 PM
#1974   $ANTH - in at .7058 Atlanta1 12/28/16 01:54:35 PM
#1973   problems? bad news? kurt_vdh 12/28/16 01:15:35 PM
#1972   Anthera Pharmaceuticals Inc (NASDAQ:ANTH) Looks Good For A trendmkr 12/28/16 12:33:07 PM
#1971   ANTH .71 seeing it being soaked up. Think PAC 12/28/16 12:01:37 PM
#1970   .69 Buy the bad news and wait for shurtha2000 12/28/16 11:41:11 AM
#1969   Ouch, think it might rebound a bit or viper666 12/28/16 12:22:56 AM
#1968   Any comments from posters on upcoming data release? W&T Capital LLC 12/27/16 10:48:59 AM
#1967   Great news for Pharma stocks , ANTH is CoinOp 12/23/16 12:57:00 AM
PostSubject